PD-L1 expression on circulating tumor cells and platelets in patients with metastatic breast cancer.
<h4>Background</h4>Immune checkpoint inhibition is effective in several cancers. Expression of programmed death-ligand 1 (PD-L1) on circulating tumor or immune effector cells could provide insights into selection of patients for immune checkpoint inhibition.<h4>Methods</h4>Wh...
Guardado en:
Autores principales: | Elizabeth P Darga, Emily M Dolce, Fang Fang, Kelley M Kidwell, Christina L Gersch, Steven Kregel, Dafydd G Thomas, Anoop Gill, Martha E Brown, Steven Gross, Mark Connelly, Michael Holinstat, Erin F Cobain, James M Rae, Daniel F Hayes, Costanza Paoletti |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/28fe13df1c2442cbb060d80eb7cf2b44 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
PD-L1 expression on circulating tumor cells and platelets in patients with metastatic breast cancer
por: Elizabeth P. Darga, et al.
Publicado: (2021) -
Circulating tumor cell number and endocrine therapy index in ER positive metastatic breast cancer patients
por: Costanza Paoletti, et al.
Publicado: (2021) -
Assessment of growth factors with three different platelet preparations, namely platelet-rich fibrin, platelet-rich plasma, and lyophilized platelet: An In vitro study
por: R Hariprasad, et al.
Publicado: (2021) -
The Ratio of Platelets to Lymphocytes Predicts the Prognosis of Metastatic Colorectal Cancer: A Review and Meta-Analysis
por: Jinming Wang, et al.
Publicado: (2021) -
Platelet-derived microparticles enhance megakaryocyte differentiation and platelet generation via miR-1915-3p
por: Mingyi Qu, et al.
Publicado: (2020)